KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $325,000 | -15.8% | 20,196 | -26.7% | 0.02% | -26.1% |
| Q4 2021 | $386,000 | +46.2% | 27,537 | +117.4% | 0.02% | +64.3% |
| Q2 2021 | $264,000 | -46.0% | 12,666 | -26.8% | 0.01% | -50.0% |
| Q1 2021 | $489,000 | -42.1% | 17,305 | -33.0% | 0.03% | -54.1% |
| Q4 2020 | $844,000 | -56.2% | 25,827 | -58.9% | 0.06% | -3.2% |
| Q3 2020 | $1,927,000 | +94.1% | 62,901 | +3.3% | 0.06% | +142.3% |
| Q2 2020 | $993,000 | +111.7% | 60,899 | +29.1% | 0.03% | +116.7% |
| Q1 2020 | $469,000 | -37.6% | 47,155 | -13.8% | 0.01% | +9.1% |
| Q4 2019 | $752,000 | +234.2% | 54,724 | +303.0% | 0.01% | +120.0% |
| Q1 2019 | $225,000 | +16.0% | 13,579 | -2.0% | 0.01% | +25.0% |
| Q4 2018 | $194,000 | -40.3% | 13,851 | -25.5% | 0.00% | -42.9% |
| Q3 2018 | $325,000 | – | 18,592 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |